CLINICAL TRIAL AGREEMENTClinical Trial Agreement • February 9th, 2024 • RedHill Biopharma Ltd. • Pharmaceutical preparations • Maryland
This Clinical Trial Agreement (“Agreement”) effective as of the date of last signature below (“Effective Date”) is entered into by and between RedHill Biopharma Ltd., an Israeli corporation, having an address at 21 Ha’arba’a St. , Tel Aviv, Israel 6473921 (“RedHill” or “Study Drug Sponsor”) and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. a Maryland non-stock Section 501(c)(3) corporation with a place of business at 6720A Rockledge Drive, Suite 100, Bethesda, MD 20817 (“HJF” or “Protocol Sponsor”). Herein each of Study Drug Sponsor and Protocol Sponsor will be a “Party” and collectively, the “Parties”.
